[go: up one dir, main page]

AR039404A1 - Combinaciones de medicamentos que contienen compuestos heterociclicos y un agente anticolinergico. aerosol para su inhalacion - Google Patents

Combinaciones de medicamentos que contienen compuestos heterociclicos y un agente anticolinergico. aerosol para su inhalacion

Info

Publication number
AR039404A1
AR039404A1 ARP030101265A ARP030101265A AR039404A1 AR 039404 A1 AR039404 A1 AR 039404A1 AR P030101265 A ARP030101265 A AR P030101265A AR P030101265 A ARP030101265 A AR P030101265A AR 039404 A1 AR039404 A1 AR 039404A1
Authority
AR
Argentina
Prior art keywords
hydrogen
pyridyl
phenyl
methyl
single bond
Prior art date
Application number
ARP030101265A
Other languages
English (en)
Inventor
Banholzer Rolf Dr
Helmut Meissner
Gerd Morschhaeuser
Pieper Michael P Dr
Pohl Gerald Dr
Reichl Richard Dr
Speck Georg Dr
Pairet Michel Dr
Montague Christopher John Dr
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of AR039404A1 publication Critical patent/AR039404A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones medicamentosas a base de un anticolinérgico 1 y compuestos heterocíclicos 2, procedimientos para su preparación, así como a su utilización en la terapia de enfermedades de las vías respiratorias. Reivindicación 1: Medicamento caracterizado por un contenido en una o varias, preferentemente una sal de la fórmula (1) en la cual: X- significa un anión monocargado negativamente, preferentemente un anión seleccionado del grupo constituido por cloruro, bromuro, yoduro, sulfato, fosfato, metanosulfonato, nitrato, maleato, acetato, citrato, fumarato, tartrato, oxalato, succinato, benzoato, y p-toluenosulfonato, en combinación con uno o varios, preferentemente un compuesto de la fórmula general (2) en la cual pueden significar: R1 hidrógeno, metilo, etilo, n-butilo, i-butilo, fenilo, 2-etilfenilo, 2-i-propilfenilo, bencilo, 4-piridilo, 2-piridilo, -CO-fenilo, CN ó, junto con R2, un puente butileno ó pentileno; R2 hidrógeno, metilo, etilo o, junto con R1, un puente butileno o pentileno o, junto con R13, un enlace sencillo o un puente butileno; R3 hidrógeno; R4 metoxi; R5 ciclohexilo, fenilo, 3-metoxicarbonilfenilo, 4-metoxicarbonilfenilo, 3-carboxifenilo, 4-carboxifenilo, CN, -COOH, -COOMe, -COOEt, 3,5-dicloro-piridina-4-il, 4-piridilo ó 4-piridil-N-óxido; A es oxígeno ó -CH2-; B es oxígeno o uno de los grupos -C(R12)(R13)- ó -CH(R15)-CH(R17)-; D es un grupo seleccionado de -CH2-CH2-, -CH(Ph)-CH2-, -CONH-, -CO-CH2-, -CH=CH-, -C(Ph)=CH-, -C(R18)(R19)-X-, -C(R19a)=Y-, -CsC- ó fenileno; R12 es hidrógeno, metilo, etilo, i-propilo, fenilo ó -CH2-CORx; R13 es hidrógeno ó, junto con R2, un enlace sencillo o un puente butileno; R15 es hidrógeno o, junto R17, un enlace sencillo; R17 es hidrógeno o, junto con R15, un enlace sencillo; R18 es hidrógeno o metilo; R19 es hidrógeno, metoxi, fenilo o CN; R19a es hidrógeno, metilo ó fenilo; Rx es hidroxi, etoxi, benciloxi, 2-feniletiloxi, 4-metil-piperazin-1-il, 4-fenilpirerazin-1-il, N-tetrahidro-isoquinolinilo, -NH-fenilo, -NH-bencilo, -NH-CH2-(4-metoxifenilo), -NH-CH2-(4-fluorofenilo), -NH-CH2-(4-clorofenilo), -NH-CH2-(2-clorofenilo), -NH-(3-piridilo), -NH-CH2-(2-piridilo), -NH-CH2-(3-piridilo), -NH-CH2-(4-piridilo), -NH-(3,5-dicloropiridin-4-il) ó -NH-(2-pirimidinilo); X es -CH2-, -S-, ó -NH-; Y es CH, CCN, CCOOEt ó CHCONH, eventualmente en forma de los isómeros ópticos individuales, mezclas de los mismos ó racematos, así como eventualmente en forma de sus sales por adición de ácidos, farmacológicamente tolerables, eventualmente en forma de sus solvatos o hidratos, así como eventualmente conjuntamente con un coadyuvante farmacéuticamente tolerable.
ARP030101265A 2002-04-12 2003-04-11 Combinaciones de medicamentos que contienen compuestos heterociclicos y un agente anticolinergico. aerosol para su inhalacion AR039404A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10216427A DE10216427A1 (de) 2002-04-12 2002-04-12 Arzneimittelkompositionen enthaltend heterocyclische Verbindungen und ein neues Anticholinergikum

Publications (1)

Publication Number Publication Date
AR039404A1 true AR039404A1 (es) 2005-02-16

Family

ID=28458800

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101265A AR039404A1 (es) 2002-04-12 2003-04-11 Combinaciones de medicamentos que contienen compuestos heterociclicos y un agente anticolinergico. aerosol para su inhalacion

Country Status (8)

Country Link
US (1) US20040002502A1 (es)
AR (1) AR039404A1 (es)
AU (1) AU2003221562A1 (es)
DE (1) DE10216427A1 (es)
PE (1) PE20040084A1 (es)
TW (1) TW200406209A (es)
UY (1) UY27759A1 (es)
WO (1) WO2003087049A2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US20040048886A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
US20040048887A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors
US20040044020A1 (en) * 2002-07-09 2004-03-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors
US20040166065A1 (en) 2002-08-14 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation comprising an anticholinergic
US7244742B2 (en) * 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
US8394236B2 (en) 2002-10-07 2013-03-12 Georgia-Pacific Consumer Products Lp Absorbent sheet of cellulosic fibers
US7494563B2 (en) 2002-10-07 2009-02-24 Georgia-Pacific Consumer Products Lp Fabric creped absorbent sheet with variable local basis weight
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7332175B2 (en) * 2003-05-27 2008-02-19 Boehringer Ingelheim International Gmbh Long-acting drug combinations for the treatment of respiratory complaints
EP1504756A1 (en) * 2003-08-06 2005-02-09 Kyowa Hakko Kogyo Co., Ltd Medicament compositions comprising a heterocyclic compound and an anticholinergic
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
EP1917253B1 (de) * 2005-08-15 2015-01-07 Boehringer Ingelheim International Gmbh Verfahren zur herstellung von betamimetika
US7599861B2 (en) 2006-03-02 2009-10-06 Convergys Customer Management Group, Inc. System and method for closed loop decisionmaking in an automated care system
US8379830B1 (en) 2006-05-22 2013-02-19 Convergys Customer Management Delaware Llc System and method for automated customer service with contingent live interaction
US7809663B1 (en) 2006-05-22 2010-10-05 Convergys Cmg Utah, Inc. System and method for supporting the utilization of machine language

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540633A1 (de) * 1975-09-12 1977-04-28 Boehringer Sohn Ingelheim Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung
US5770738A (en) * 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
PT771794E (pt) * 1995-05-19 2006-09-29 Kyowa Hakko Kogyo Kk Compostos heterociclicos contendo oxigenio
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US6706726B2 (en) * 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
US20020193393A1 (en) * 2001-03-07 2002-12-19 Michel Pairet Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US20040048887A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors
US20040044020A1 (en) * 2002-07-09 2004-03-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
US20040048886A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists
US20040166065A1 (en) * 2002-08-14 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation comprising an anticholinergic
US7244742B2 (en) * 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
US7332175B2 (en) * 2003-05-27 2008-02-19 Boehringer Ingelheim International Gmbh Long-acting drug combinations for the treatment of respiratory complaints
US7273603B2 (en) * 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
TWI259994B (en) * 2003-07-21 2006-08-11 Ali Corp Adaptive multiple levels step-sized method for time scaling
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
US20050154006A1 (en) * 2004-01-09 2005-07-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on a scopineester and nicotinamide derivatives
US20050186175A1 (en) * 2004-02-20 2005-08-25 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins

Also Published As

Publication number Publication date
TW200406209A (en) 2004-05-01
US20040002502A1 (en) 2004-01-01
WO2003087049A2 (de) 2003-10-23
WO2003087049A3 (de) 2004-02-05
DE10216427A1 (de) 2003-10-23
AU2003221562A1 (en) 2003-10-27
AU2003221562A8 (en) 2003-10-27
UY27759A1 (es) 2003-11-28
PE20040084A1 (es) 2004-04-01

Similar Documents

Publication Publication Date Title
AR039404A1 (es) Combinaciones de medicamentos que contienen compuestos heterociclicos y un agente anticolinergico. aerosol para su inhalacion
ES2655527T3 (es) Derivados novedosos de amino pirimidina
ES2625944T3 (es) Inhibidores de tirosina cinasa de Bruton
CA3224341A1 (en) Pharmaceutical combinations comprising a tead inhibitor and uses thereof for the treatment of cancers
CA2749730C (en) Sgc stimulators of sgc activators in combination with pde5 inhbitors for the treatment of erectile dysfunction
BR0309345A (pt) Composto ou sais farmaceuticamente aceitáveis do mesmo, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou de distúrbios de dano intelectual, e de jetlag, interrupção do hábito de fumar, dependência de nicotina, ânsias, dor e colite ulcerativa
BR112020014160A2 (pt) Compostos de benzamida
RU2006144123A (ru) Новые энантиомерночистые в-агонисты, способ их получения и их применение в качестве лекарственных средств
NO20060974L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
AR055669A1 (es) Derivados de 3h - imidazo[4, 5 -b]piridina como inhibidores selectivos de gsk3, metodos e internediarios para su preparacion, composiciones farmaceuticas que los contienen y su uso para la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y mentales.
CY1108776T1 (el) Σκευασμα αερολυματος για εισπνοη που περιεχει αντιχολινεργικο
NO20070837L (no) Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
BRPI0518231A2 (pt) derivados de 2-amido-4-feniltiazol, o respectivo preparo e a respectiva aplicaÇço em terapÊutica
RU2006119914A (ru) Применение ингибиторов глюкозидазы для терапии муковисцидоза
NO20044545L (no) Piperidin-eller 8-aza-bicyklo[3.2.1.]okt-3-yl derivater som er nyttige som modulatorer for kemokireseptoraktivitet (spesielt CCR5)
WO2004000355A1 (en) Combination treatment for depression and anxiety by nk1 and nk3 antagonists
ES2220975T3 (es) Tratamiento de trastornos producidos por factores de crecimiento de citoquina.
JP2009518423A (ja) 統合失調症の副作用および陰性症状を治療するためのｃｂ１アンタゴニストの使用
AR038824A1 (es) Composiciones de medicamentos que, junto a agentes colinergicos, contienen compuestos heterociclicos
CA2408036A1 (en) Combination of growth hormone secretagogues and antidepressants
AU700520B2 (en) NK-1 receptor antagonists for the treatment of cancer
ES2634026T3 (es) Composiciones medicinales
NO20040382L (no) Kinolinderivater og anvendelse derav som antitumormidler
ES2532000T3 (es) Composición farmacéutica para el tratamiento de la dependencia del alcohol
MY138940A (en) Inhalable formulation of a solution containing a tiotropium salt.

Legal Events

Date Code Title Description
FB Suspension of granting procedure